House Committee Approves $5 Million to Improve Pediatric Lab Testing
The funding, allocated to the Centers for Disease Control and Prevention, aims to establish more accurate normal ranges for children’s medical results.
The funding, allocated to the Centers for Disease Control and Prevention, aims to establish more accurate normal ranges for children’s medical results.
The new triple quadrupole mass spectrometry system aims to increase sample throughput and simplify interference removal.
The mRNA-based test aims to provide objective data to help clinicians distinguish between psychiatric conditions that often share symptoms.
Cleveland Diagnostics has received ISO 13485:2016 certification for its IsoPSA Assay, supporting scaled U.S. commercialization following recent FDA approval for prostate cancer risk assessment.
Applicable laboratories are required to report information to CMS for each clinical diagnostic laboratory test that the laboratory furnishes.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
Co-Diagnostics has completed its assay development strategy for Bundibugyo virus, following the WHO’s emergency declaration and CDC’s updated traveler screening measures amid ongoing Ebola outbreaks in the DRC and Uganda.
Position your laboratory for the future of hemostasis testing This sponsored white paper explores how advances in automation, workflow optimization, and intelligent coagulation analysis are helping laboratories improve...